(1 - 12 from 16
)
History of Changes for Study: NCT Clinical Trialsclinicaltrials.gov › history › NCT
clinicaltrials.gov
Official Title: Patrick Wen, MD. Affiliation: Dana-Farber Cancer Institute. Collaborators: Merck Sharp & Dohme Corp.
Targeted drug combination shows unprecedented Newswisewww.newswise.com › articles › media-article
www.newswise.com
Patrick Wen, MD. Dana-Farber Cancer Institute. Patrick Wen, MD. « Targeted drug combination shows unprecedented activity in some highly aggressive brain ...
myCare Clinical Studies Show Cellworks Singula™ Achieves ...www.globenewswire.com › news-release ›
www.globenewswire.com
Patrick Wen, MD, Director, Center For Neuro-Oncology, Dana-Farber Cancer Institute; Professor, Neurology, Harvard Medical School; and co- ...
sorted by relevance / date